Genomed Stock

Genomed EBIT Margin

The EBIT Margin (Operating Margin) of Genomed (GEN.WA) as of Jul 26, 2026 is 5.23 %. In the previous year, EBIT Margin (Operating Margin) was 5.53 % — a change of -5.42% (lower).

EBIT Margin

5.23 %

YoY

-5.42%

Last updated:

EBIT Margin (Operating Margin) of Genomed is 2026 5.23 % . EBIT Margin (Operating Margin) of Genomed was 2025 5.53 % . It decreases by -5.42% lower compared to the previous year.

For Genomed, the operating (EBIT) margin of 5.2% is up versus 2.5% a few years ago.

Access this data via the Eulerpool API

Genomed Stock analysis

What does Genomed do? Genomed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomed stock

EBIT Margin (Operating Margin) of Genomed is 5.23 % in 2026.

Access this data via the Eulerpool API

Margins — Genomed

All Key Metrics — Genomed